510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K022331Substantially Equivalent

Advia 120 Hematology System, Cerebrospinal Fluid Method

Bayer Diagnostics Corp., Tarrytown NY / Special, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K022331 is the FDA 510(k) clearance record for ADVIA 120 HEMATOLOGY SYSTEM, CEREBROSPINAL FLUID METHOD, a class II device, cleared for Bayer Diagnostics Corp. on under FDA product code GKL (Counter, Cell, Automated (Particle Counter)). FDA records list 32 510(k) clearances for Bayer Diagnostics Corp., from to . As of , FDA records show no recalls naming K022331.

Clearance record

Decision date
Received
(55 days to decision)
Product code
GKL Counter, Cell, Automated (Particle Counter)
Regulation
21 CFR 864.5200
Device class
Class II
Review panel
Hematology
Applicant
Bayer Diagnostics Corp. 511 Benedict Ave., Tarrytown NY
510(k) summary
Summary PDF
Third party review
No

Clearances, product code GKL

Trailing 12 months

FDA records hold no clearances under product code GKL in the trailing twelve months.

FDA records show no clearances under product code GKL in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code GKL, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260